Total Payments
$84,235
2024 Payments
$19,060
Companies
19
Transactions
102
Medicare Patients
2,792
Medicare Billing
$219,212
Payment Breakdown by Category
Other$38,450 (45.6%)
Consulting$38,138 (45.3%)
Food & Beverage$4,198 (5.0%)
Travel$3,335 (4.0%)
Education$61.21 (0.1%)
Gifts$52.97 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $38,138 | 15 | 45.3% |
| Honoraria | $30,500 | 13 | 36.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,950 | 1 | 9.4% |
| Food and Beverage | $4,198 | 60 | 5.0% |
| Travel and Lodging | $3,335 | 10 | 4.0% |
| Education | $61.21 | 1 | 0.1% |
| Gift | $52.97 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Therapeutics plc | $52,983 | 41 | $0 (2023) |
| Amgen Inc. | $15,241 | 7 | $0 (2024) |
| Genentech, Inc. | $4,888 | 2 | $0 (2023) |
| H. Lundbeck A S | $2,800 | 1 | $0 (2023) |
| ARGENX US, INC. | $2,346 | 2 | $0 (2023) |
| ABBVIE INC. | $2,188 | 17 | $0 (2024) |
| Janssen Research & Development, LLC | $1,275 | 1 | $0 (2024) |
| Stryker Corporation | $698.77 | 8 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $564.01 | 6 | $0 (2019) |
| AXOGEN | $239.65 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $19,060 | 31 | Amgen Inc. ($15,241) |
| 2023 | $25,995 | 20 | Horizon Therapeutics plc ($15,424) |
| 2022 | $10,528 | 9 | Horizon Therapeutics plc ($10,270) |
| 2021 | $3,101 | 3 | Horizon Therapeutics plc ($3,007) |
| 2020 | $22,145 | 20 | Horizon Therapeutics plc ($22,125) |
| 2019 | $2,772 | 10 | Horizon Therapeutics plc ($2,157) |
| 2018 | $284.16 | 3 | Allergan Inc. ($129.92) |
| 2017 | $350.00 | 6 | Mallinckrodt LLC ($205.93) |
All Payment Transactions
102 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $147.10 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/19/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $70.35 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/04/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $91.55 | General |
| Category: FACIAL AESTHETICS | ||||||
| 09/21/2024 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $303.19 | General |
| 09/21/2024 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $137.12 | General |
| 09/21/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $78.33 | General |
| 09/21/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $68.33 | General |
| 09/21/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $33.33 | General |
| 09/20/2024 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $417.65 | General |
| 09/20/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $118.82 | General |
| 09/20/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $70.00 | General |
| 09/20/2024 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $65.10 | General |
| 09/20/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $60.00 | General |
| 09/20/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $25.00 | General |
| 09/20/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $13.35 | General |
| 09/19/2024 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $417.65 | General |
| 09/19/2024 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $155.12 | General |
| 09/19/2024 | ABBVIE INC. | — | Gift | In-kind items and services | $33.57 | General |
| 08/24/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $35.91 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 08/24/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $35.91 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 08/23/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $101.53 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 08/22/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $99.61 | General |
| Category: EYE CARE | ||||||
| 08/15/2024 | Stryker Corporation | CORE (Device) | Food and Beverage | In-kind items and services | $73.47 | General |
| Category: NEURO SPINE ENT | ||||||
| 08/15/2024 | Stryker Corporation | NA (Device) | Food and Beverage | In-kind items and services | $55.74 | General |
| Category: NEURO | ||||||
| 08/15/2024 | Stryker Corporation | SCOPIS ENT (Device) | Food and Beverage | In-kind items and services | $53.88 | General |
| Category: INSTRUMENTS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 750 | 863 | $977,779 | $63,631 |
| 2022 | 15 | 800 | 891 | $660,862 | $57,218 |
| 2021 | 11 | 639 | 717 | $445,456 | $40,760 |
| 2020 | 15 | 603 | 687 | $1.1M | $57,603 |
Total Patients
2,792
Total Services
3,158
Medicare Billing
$219,212
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 145 | 162 | $19,984 | $14,404 | 72.1% |
| 67911 | Correction of widely-opened upper eyelid | Facility | 2023 | 17 | 21 | $350,144 | $9,759 | 2.8% |
| 67950 | Reconstruction of eyelid margin | Facility | 2023 | 22 | 24 | $446,288 | $8,992 | 2.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 39 | 56 | $10,382 | $6,662 | 64.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 48 | 48 | $8,736 | $5,715 | 65.4% |
| 67840 | Removal of growth of eyelid | Office | 2023 | 19 | 33 | $6,710 | $3,908 | 58.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 52 | 56 | $5,959 | $3,149 | 52.8% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 104 | 120 | $21,486 | $2,988 | 13.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 14 | 14 | $3,556 | $2,338 | 65.7% |
| 68840 | Probing of nasal tear duct | Office | 2023 | 14 | 15 | $13,425 | $2,199 | 16.4% |
| 67875 | Temporary closure of eyelids by suture | Facility | 2023 | 22 | 24 | $66,270 | $1,204 | 1.8% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 16 | 16 | $3,760 | $1,091 | 29.0% |
| 92285 | Photography of content of eyes | Office | 2023 | 214 | 245 | $19,025 | $649.38 | 3.4% |
| 92133 | Imaging of optic nerve | Office | 2023 | 24 | 29 | $2,054 | $573.44 | 27.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 144 | 152 | $19,664 | $12,743 | 64.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 80 | 102 | $18,036 | $12,448 | 69.0% |
| 67950 | Reconstruction of eyelid margin | Facility | 2022 | 17 | 18 | $300,336 | $6,426 | 2.1% |
| 67911 | Correction of widely-opened upper eyelid | Facility | 2022 | 11 | 12 | $214,668 | $5,503 | 2.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 47 | 47 | $9,154 | $5,280 | 57.7% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 119 | 131 | $19,526 | $3,043 | 15.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 19 | 19 | $4,826 | $3,042 | 63.0% |
| 68840 | Probing of nasal tear duct | Office | 2022 | 12 | 12 | $11,310 | $1,857 | 16.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 28 | 29 | $2,621 | $1,613 | 61.6% |
| 67840 | Removal of growth of eyelid | Office | 2022 | 11 | 13 | $2,130 | $1,354 | 63.6% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 14 | 14 | $3,290 | $1,021 | 31.0% |
About Dr. Andrea Kossler, MD
Dr. Andrea Kossler, MD is a Ophthalmology healthcare provider based in Stanford, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/28/2008. The National Provider Identifier (NPI) number assigned to this provider is 1285884106.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrea Kossler, MD has received a total of $84,235 in payments from pharmaceutical and medical device companies, with $19,060 received in 2024. These payments were reported across 102 transactions from 19 companies. The most common payment nature is "Consulting Fee" ($38,138).
As a Medicare-enrolled provider, Kossler has provided services to 2,792 Medicare beneficiaries, totaling 3,158 services with total Medicare billing of $219,212. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmology, Ophthalmic Plastic and Reconstructive Surgery
- Location Stanford, CA
- Active Since 09/28/2008
- Last Updated 04/04/2024
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1285884106
Products in Payments
- TEPEZZA (Drug) $49,289
- TEPEZZA (Biological) $15,241
- Enspryng (Biological) $4,888
- VYEPTI (Biological) $2,800
- VYVGART (Drug) $2,346
- ACTHAR (Biological) $590.15
- NA (Device) $273.52
- Avance Nerve Graft (Device) $175.00
- XDEMVY (Drug) $173.35
- XPRESS ENT DILATION SYSTEM (Device) $152.88
- Erivedge (Biological) $119.90
- OZURDEX (Drug) $99.61
- BOTOX (Biological) $91.55
- UNIVERSAL UPPER-FACE (Device) $81.44
- OFIRMEV (Drug) $73.85
- CORE (Device) $73.47
- AxoGuard Nerve Protector (Device) $64.65
- Universal Upper-Face (Device) $63.58
- SCOPIS ENT (Device) $53.88
- None Specified (Medical Supply) $19.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Stanford
Kuldev Singh, Md, MD
Ophthalmology — Payments: $1.9M
Ophthalmology $1.9M
Ehsan Rahimy, Md, MD
Ophthalmology — Payments: $1.3M
Ophthalmology $1.3M
Quan Nguyen, Md, MD
Ophthalmology — Payments: $999,300
Ophthalmology $999,300
Diana Do, Md, MD
Ophthalmology — Payments: $383,793
Ophthalmology $383,793
Theodore Leng, Md, MD
Ophthalmology — Payments: $246,136
Ophthalmology $246,136
Robert Chang, Md, MD
Ophthalmology — Payments: $107,945
Ophthalmology $107,945